Between success with a pancreatic cancer drug and now success with an mRNA neoantigen vaccine, it has been a banner year for ...
Capricor Therapeutics is trying to stave off FDA rejection of its cell therapy for Duchenne muscular dystrophy.
Washington has rediscovered faith as a delivery mechanism. The bigger opportunity is faith as a source of capital,” writes Dr ...
Regulatory flexibility can be exercised in rare disease without sacrificing rigor,” writes Mindy Leffler, whose son has ...
Males make up about a third of the population struggling with eating disorders in the United States. While these conditions ...
A Regeneron drug that treats an ultra-rare disease that causes bone to form where it's not meant to be has won approval.
The Trump administration did not overhaul the childhood vaccine schedule or flip the food pyramid until Heidi Overton, deputy ...
Brain organoids kept alive more than five years continued to develop and mature, and showed molecular and genetic signatures ...
Erica Schwartz, the new director of the Centers for Disease Control and Prevention, told agency staff on Wednesday that she ...
The American Cancer Society had an optics problem: its annual Wine and Spirits Industry's Gala. It decided to do something ...
Merck and Moderna's mRNA cancer vaccine, an expected nominee to lead the FDA, and more biotech news from The Readout ...
President Trump is expected to nominate Heidi Overton, White House deputy director of domestic policy, to serve as the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results